The long-term outcome of anti-Jo-1-positive inflammatory myopathies

Journal of Neurology

Volumn 251, Issue 7, 2004, Pages 859-864

  Späth, Michael ^a   Schröder, Mira ^a   Schlotter Weigel, Beate ^a   Walter, Maggie C ^a   Hautmann, Hubert ^b   Leinsinger, Gerda ^b   Pongratz, Dieter ^a   Müller Felber, Wolfgang ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti Jo 1 antibodies; Interstitial lung disease; Myopathy; Myositis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; JO 1 ANTIBODY; METHOTREXATE; PREDNISONE; SYNTHETASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTISYNTHETASE SYNDROME; ARTHROPATHY; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFECT; DRUG FATALITY; ELECTROMYOGRAM; ELECTROMYOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; FUNCTION TEST; HEMORRHAGIC CYSTITIS; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIVER DISEASE; LONG TERM CARE; LUNG FUNCTION TEST; MALE; MORTALITY; MUSCLE FUNCTION; MYOSITIS; NEUROMUSCULAR FUNCTION; NONHODGKIN LYMPHOMA; OSTEOPOROSIS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; VERTEBRA; VERTEBRA FRACTURE;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; DISEASE PROGRESSION; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 3442880479     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Angelini C, Menegazzo E, Fanin M (1993) Multifactorial study of inflammatory myopathies. Report of 29 cases. Ital J Neurol Sci 14:69-76
2. Arnett FC, Whelton JC, Zizic TM, Stevens MB (1973) Methotrexate therapy in polymyositis. Ann Rheum Dis 32:536-546
3. Arnett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M (1981) The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol 8:925-930
4. Arsura EL, Greenberg AS (1988) Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 18:29-37
5. Cherin P, Herson S, Wechsler B, Piette JC, Bletry O, Coutellier A, Ziza JM, Godeau P (1991) Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 91:162-168
6. Clarke AE, Bloch DA, Medsger TA Jr, Oddis CV (1995) A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 38:1218-1224
7. Cronin ME, Miller FW, Hicks JE, Dalakas M, Plotz PH (1989) The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy. J Rheumatol 16:1225-1228
8. Dalakas MC (1998) Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 51:S37-45
9. Fischer E, Thiele A, Stierle HE, Lang B (1995) Anti-Jo-1-Antikörper: Spezifische Autoantikörper für Polymyositis mit interstitieller Lungenfibrose. 2 Fallvorstellungen [Anti-Jo-1 antibodies: specific autoantibodies for polymyositis with interstitial pulmonary fibrosis. 2 case reports]. Z Rheumatol 54:171-177
10. Gruhn WB, Diaz-Buxo JA (1987) Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 14:1045-1047
11. Haga HJ, D'Cruz D, Asherson R, Hughes GR (1992) Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis. Ann Rheum Dis 51:885-888
12. Hirakata M, Nagai S (2000) Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 12:501-508
13. Joffe MM, Love LA, Leff RL, Fraser DD, Targoff IN, Hicks JE, Plotz PH, Miller FW (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94:379-387
14. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70:360-374
15. Maeda K, Kimura R, Ko muta K, Igarashi T (1997) Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol 26:24-29
16. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ (1990) Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77:1019-1038
17. Mitsunaka H, Tokuda M, Hiraishi T, Dobashi H, Takahara J (2000) Combined use of cyclosporine A and methotrexate in refractory polymyositis. Scand J Rheumatol 29:192-194
18. Oddis CV (2000) Current approach to the treatment of polymyositis and dermatomyositis. Curr Opin Rheumatol 12:492-497
19. Oddis CV, Sciurba FC, Elmagd KA, Starzl TE (1999) Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353:1762-1763
20. Phillips BA, Zilko P, Garlepp MJ, Mastaglia FL (1998) Frequency of relapses in patients with polymyositis and dermatomyositis. Muscle Nerve 21:1668-1672
21. Targoff IN (2000) Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol 12:475-481
22. Vencovsky J, Jarosova K, Machacek S, Studynkova J, Kafkova J, Bartunkova J, Nemcova D, Charvat F (2000) Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29:95-102
23. Villalba L, Hicks JE, Adams EM, Sherman JB, Gourley MF, Leff RL, Thornton BC, Burgess SH, Plotz PH, Miller FW (1998) Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum 41:392-399
24. Yoshida T, Koga H, Saitoh F, Sakamoto M, Harada M, Yoshida H, Sakisaka S, Sata M (1999) Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Intern Med 38:733-738